Global Small Interfering RNA (siRNA) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Small Interfering RNA (siRNA) Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP's advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
Global Small Interfering RNA (siRNA) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Cancer and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Small Interfering RNA (siRNA) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Small Interfering RNA (siRNA) key companies include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs and Quantabio, etc. Agilent Technologies, Merck KGaA, QIAGEN (Exiqon) are top 3 players and held % share in total in 2022.
Small Interfering RNA (siRNA) can be divided into General Chemical Synthesis of siRNA and Sterol Modified Chemical Synthesis of siRNA, etc. General Chemical Synthesis of siRNA is the mainstream product in the market, accounting for % share globally in 2022.
Small Interfering RNA (siRNA) is widely used in various fields, such as Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, etc. Cancer provides greatest supports to the Small Interfering RNA (siRNA) industry development. In 2022, global % share of Small Interfering RNA (siRNA) went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Small Interfering RNA (siRNA) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Small Interfering RNA (siRNA) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Small Interfering RNA (siRNA) introduction, etc. Small Interfering RNA (siRNA) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Small Interfering RNA (siRNA) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Global Small Interfering RNA (siRNA) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Cancer and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Small Interfering RNA (siRNA) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Small Interfering RNA (siRNA) key companies include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs and Quantabio, etc. Agilent Technologies, Merck KGaA, QIAGEN (Exiqon) are top 3 players and held % share in total in 2022.
Small Interfering RNA (siRNA) can be divided into General Chemical Synthesis of siRNA and Sterol Modified Chemical Synthesis of siRNA, etc. General Chemical Synthesis of siRNA is the mainstream product in the market, accounting for % share globally in 2022.
Small Interfering RNA (siRNA) is widely used in various fields, such as Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, etc. Cancer provides greatest supports to the Small Interfering RNA (siRNA) industry development. In 2022, global % share of Small Interfering RNA (siRNA) went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Small Interfering RNA (siRNA) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Small Interfering RNA (siRNA) market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Small Interfering RNA (siRNA) introduction, etc. Small Interfering RNA (siRNA) Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Small Interfering RNA (siRNA) market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices